Compound Monograph

6-Paradol

Phenolics Phenylpropanoids Natural (plant-derived)

6-Paradol is a pungent vanillyl-ketone phenol — the signature hot principle of grains of paradise (Aframomum melegueta) and a minor constituent of ginger, where it also forms in vivo as the reduced (dihydro) metabolite of 6-shogaol. Its distinctive angle is a thermogenic, brown-fat-activating anti-obesity signal, alongside a classic ginger-phenol chemoprevention line.

Sources · 4

Where Does It Come From?

6-Paradol is a naturally occurring vanillyl-ketone phenol (pungent gingerol-type aryl alkanone), found in Grains of paradise, Ginger and 2 other sources. It is well tolerated orally (low toxicity).

Also found in
Formed in vivo as a reduced metabolite of dietary 6-shogaol Monograph coming soon
Grains of paradise Monograph coming soon
Related Aframomum / Zingiberaceae spices Monograph coming soon

Concentration

Content by Source

Concentrations not reported. No percent-dry-weight or mg/g figures have been published for this compound in its source plants.

6-Paradol at a Glance

6-Paradol is a pungent phenolic ketone from the same vanillyl-ketone family as ginger’s 6-gingerol and 6-shogaol. Structurally it is the reduced (dihydro) form of 6-shogaol — the double bond in shogaol’s side chain is saturated — and it arises in the body as an in-vivo metabolite of shogaol and gingerol as well as occurring pre-formed in the plant 7Reference 7Almatroudi A et al. · 2019ReviewGinger: a novel strategy to battle cancer through modulating cell signalling pathways: a reviewView study →.

Its defining natural home is grains of paradise (Aframomum melegueta), a West African spice in the ginger family whose characteristic heat is largely down to 6-paradol; it is also a minor pungent constituent of ordinary ginger rhizome, alongside the gingerols and shogaols.

The compound-unique story here is thermogenic / anti-obesity: a small set of human trials of grains-of-paradise extract point to brown adipose tissue (BAT) activation and increased energy expenditure 1,2Reference 1Sugita J et al. · 2013Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in menView study →Reference 2Sugita J et al. · 2014Daily ingestion of grains of paradise (Aframomum melegueta) extract increases whole-body energy expenditure and decreases visceral fat in humansView study →. Around that sits the broader ginger-phenol repertoire — a well-developed preclinical chemoprevention line 3,4,5Reference 3Chung WY et al. · 2001AnimalAntioxidative and antitumor promoting effects of [6]-paradol and its homologs on murine skinView study →Reference 4Keum YS et al. · 2002Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cellsView study →Reference 5Bode AM et al. · 2001Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerolView study →, plus anti-inflammatory, neuroprotective and antioxidant signals 6,7Reference 6Gaire BP et al. · 2015Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microgliaView study →Reference 7Almatroudi A et al. · 2019ReviewGinger: a novel strategy to battle cancer through modulating cell signalling pathways: a reviewView study →. As with most ginger phenols, the honest caveat is that the human data test a whole spice extract, not the isolated molecule.

The Brown-Fat / Thermogenesis Angle

This is what makes 6-paradol distinctive among the ginger phenols and the reason grains of paradise turns up in “brown fat” and metabolism supplements.

Brown adipose tissue burns energy to produce heat (cold- and diet-induced thermogenesis), so activating it raises whole-body energy expenditure. In a controlled human study, a single 40 mg dose of grains of paradise extract significantly increased energy expenditure over the following two hours in men who had detectable active BAT on imaging, but not in those without it — while placebo did nothing 1Reference 1Sugita J et al. · 2013Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in menView study →. A follow-up trial gave non-obese women 30 mg/day for four weeks and found a decrease in visceral fat area (placebo slightly increased it) together with raised whole-body energy expenditure 2Reference 2Sugita J et al. · 2014Daily ingestion of grains of paradise (Aframomum melegueta) extract increases whole-body energy expenditure and decreases visceral fat in humansView study →.

The proposed mechanism is the same TRPV1 → sympathetic nervous system → BAT axis that capsaicin and other pungent food molecules use: the pungency that makes the spice hot is coupled to the thermogenic effect. This is a genuinely interesting, human-level signal — but read it carefully. The intervention is standardised grains-of-paradise extract, of which 6-paradol is the marker pungent principle, not purified 6-paradol; the samples are small; and the effect is conditional on already having active brown fat.

What It's Used For

Beyond thermogenesis, 6-paradol carries the classic ginger-phenol activities — chemoprevention, anti-inflammatory/neuroprotective and antioxidant — mostly in cell and rodent models, and often as one of several pungent phenols studied together.

Thermogenesis / anti-obesity — the standout, and the only human data:grains-of-paradise extract activates brown fat and raises energy expenditure, with a small visceral-fat reduction over four weeks — but tested as the spice extract, not the isolated molecule 1,2Reference 1Sugita J et al. · 2013Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in menView study →Reference 2Sugita J et al. · 2014Daily ingestion of grains of paradise (Aframomum melegueta) extract increases whole-body energy expenditure and decreases visceral fat in humansView study →.
Chemoprevention — a strong, long-standing preclinical line:isolated 6-paradol induces caspase-3-dependent apoptosis in cancer cells and cuts chemically-induced mouse skin tumours, blocking tumour-promoter signalling 3,4,5Reference 3Chung WY et al. · 2001AnimalAntioxidative and antitumor promoting effects of [6]-paradol and its homologs on murine skinView study →Reference 4Keum YS et al. · 2002Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cellsView study →Reference 5Bode AM et al. · 2001Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerolView study →.
Anti-inflammatory / neuroprotective & antioxidant:6-paradol damps microglial inflammation and protects the brain after experimental stroke, and scavenges radicals — all animal/in-vitro 6,7Reference 6Gaire BP et al. · 2015Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microgliaView study →Reference 7Almatroudi A et al. · 2019ReviewGinger: a novel strategy to battle cancer through modulating cell signalling pathways: a reviewView study →. No claim here rests on human outcomes for the pure compound.
Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Note that the strongest-scored row rests on whole grains-of-paradise extract, while the chemoprevention row rests on the isolated molecule — read the per-row basis.

Mechanisms

Target / pathwayEffectRelevant to
TRPV1 → sympathetic nervous system → brown adipose tissuepungency-coupled BAT activation → raised thermogenesis / energy expenditure
thermogenesis / anti-obesity
Caspase-3 (pro-caspase-3 cleavage)induces apoptosis in carcinoma cells
anticancer / chemoprevention
AP-1 / EGF-induced signallinginhibits tumour-promoter-driven cell transformation
anticancer / chemoprevention
iNOS / NO and pro-inflammatory cytokines (IL-6, TNF-α) in microgliasuppresses neuroinflammatory activation
anti-inflammatory / neuroprotective
Myeloperoxidase, H₂O₂, ornithine-decarboxylase (skin)anti-inflammatory / antitumour-promoting in mouse skin
chemoprevention
Phenolic radical scavengingcontributes to antioxidant capacity
antioxidant

The TRPV1-thermogenesis axis is the load-bearing, molecule-specific point; the caspase-3 / AP-1 chemoprevention mechanisms are shared with the wider gingerol/shogaol family.

Pharmacokinetics

Dedicated human pharmacokinetics for isolated 6-paradol are sparse. Its most important PK fact is metabolic: 6-paradol is itself a reduced (dihydro) in-vivo metabolite of 6-shogaol (and, via shogaol, of gingerol), formed when the enone side chain of shogaol is saturated 6Reference 6Gaire BP et al. · 2015Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microgliaView study →. As a small, lipophilic vanillyl-phenol it is expected to be absorbed and, like its ginger-phenol relatives, extensively conjugated (glucuronidation/sulfation) — but the specific oral bioavailability, half-life and active-metabolite profile of the pure compound in humans have not been well characterised, and its systemic exposure from dietary spice intake is low.

Clinical Trials

Human trials exist only for grains-of-paradise extract as a thermogenic/anti-obesity intervention 1,2Reference 1Sugita J et al. · 2013Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in menView study →Reference 2Sugita J et al. · 2014Daily ingestion of grains of paradise (Aframomum melegueta) extract increases whole-body energy expenditure and decreases visceral fat in humansView study → — not for purified 6-paradol, and not for its anticancer or neuroprotective activities.

CompletedPlannedTerminatedPreclinical
Grains-of-paradise extract: 2 small metabolic trials (BAT / energy expenditure / visceral fat)——Chemoprevention (apoptosis, skin tumours, AP-1); neuroprotection; antioxidant — all isolate

Last checked: July 2026.

Isolate vs. Plant Studies

6-Paradol splits its evidence unusually cleanly. The human data are whole-extract: grains of paradise (Aframomum melegueta) standardised extract, with 6-paradol as its marker pungent principle, drives the brown-fat and energy-expenditure findings 1,2Reference 1Sugita J et al. · 2013Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in menView study →Reference 2Sugita J et al. · 2014Daily ingestion of grains of paradise (Aframomum melegueta) extract increases whole-body energy expenditure and decreases visceral fat in humansView study → — so the thermogenic story cannot be attributed to the pure molecule alone. The preclinical data, by contrast, are largely isolate: purified 6-paradol was the tested agent in the apoptosis, skin-tumour, AP-1 and neuroinflammation studies 3,4,5,6Reference 3Chung WY et al. · 2001AnimalAntioxidative and antitumor promoting effects of [6]-paradol and its homologs on murine skinView study →Reference 4Keum YS et al. · 2002Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cellsView study →Reference 5Bode AM et al. · 2001Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerolView study →Reference 6Gaire BP et al. · 2015Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microgliaView study →, which is a genuine strength for mechanism even though none reaches human outcomes. The practical reading: a compelling molecule mechanistically, a compelling spice extract clinically — with the bridge between them (a trial of isolated 6-paradol) still missing.

Prevalence in Nature

6-Paradol’s headline source is grains of paradise (Aframomum melegueta), a West African member of the ginger family (Zingiberaceae) whose seeds are used as a peppery spice; 6-paradol is the constituent most responsible for their pungency, and phytochemical work on the seeds routinely isolates it alongside related paradols and gingerols 8,9Reference 8Abdel-Naim AB et al. · 2017Phenolics isolated from Aframomum meleguta enhance proliferation and ossification markers in bone cellsView study →Reference 9Mohammed A et al. · 2017Inhibition of key enzymes linked to type 2 diabetes by compounds isolated from Aframomum melegueta fruitView study →. It also occurs as a minor pungent phenol of common ginger (Zingiber officinale) rhizome, where the dominant pungent principles are the gingerols and, in dried/heated ginger, the shogaols.

Beyond pre-formed plant content, 6-paradol is generated in vivo as the reduced metabolite of dietary 6-shogaol, so it can arise from ordinary ginger consumption as well as from grains of paradise 6Reference 6Gaire BP et al. · 2015Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microgliaView study →. Quantitative seed/rhizome concentrations are not consistently reported in the sources reviewed here, so no comparative content figures are given.

Discovery & Synthesis

The paradol name derives directly from grains of paradise (Aframomum melegueta), the spice from which the pungent principle was characterised. As a member of the gingerol/shogaol family it was drawn into pharmacological study chiefly through ginger chemoprevention research from the late 1990s — Surh and colleagues’ work on the anti-tumour-promoting pungent phenols of ginger established 6-paradol as an active chemopreventive molecule 3,5Reference 3Chung WY et al. · 2001AnimalAntioxidative and antitumor promoting effects of [6]-paradol and its homologs on murine skinView study →Reference 5Bode AM et al. · 2001Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerolView study →. Its structural relationship to shogaol (6-paradol is the dihydro/reduced form) means it is readily accessed by hydrogenation of the corresponding shogaol, and synthetic dehydroparadol analogues have been made to probe structure–activity in the apoptosis work 4Reference 4Keum YS et al. · 2002Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cellsView study →. Manufacture today is essentially extraction from grains of paradise / ginger for research and supplement use rather than large-scale total synthesis.

Patents: not yet researched.

Toxicity & Safety

6-Paradol carries a low toxicity flag. It is a pungent constituent of edible spices — grains of paradise and ginger — consumed by humans for centuries as food, and the standardised grains-of-paradise extract used in the metabolic trials (30–40 mg) was given to healthy volunteers without reported adverse effects 1,2Reference 1Sugita J et al. · 2013Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in menView study →Reference 2Sugita J et al. · 2014Daily ingestion of grains of paradise (Aframomum melegueta) extract increases whole-body energy expenditure and decreases visceral fat in humansView study →. As a TRPV1-active pungent molecule, its most predictable effects are the ordinary ones of hot spices: a warming sensation and potential gastrointestinal irritation at high intake.

Safety at a Glance
Low / no toxicity
  • Dietary spice constituent. A long-consumed pungent principle of grains of paradise and ginger; the extract used in human trials was well tolerated at 30–40 mg.
  • Pungency / GI effects at high intake. TRPV1-mediated warmth and possible gastric irritation, as with other hot spices, at large doses.
  • No isolated-compound safety dataset. There is no dedicated toxicology, drug-interaction, or reproductive-safety package for purified 6-paradol; intake decisions for the spice or a supplement belong on the herb/product page, not this molecule page.

Dosage

There is no established therapeutic dose for isolated 6-paradol. The only human dosing figures come from grains-of-paradise (Aframomum melegueta) extract, standardised to its pungent phenols:

ApplicationFormDose (studied)
Acute brown-fat / energy expenditure 1Reference 1Sugita J et al. · 2013Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in menView study →Grains-of-paradise extract~40 mg, single dose
4-week visceral-fat / energy expenditure 2Reference 2Sugita J et al. · 2014Daily ingestion of grains of paradise (Aframomum melegueta) extract increases whole-body energy expenditure and decreases visceral fat in humansView study →Grains-of-paradise extract~30 mg/day

These are doses of a whole spice extract (with 6-paradol as its marker pungent principle), studied in small trials — not doses of the purified molecule, and not a personal recommendation.

References

  1. Sugita J, Yoneshiro T, Hatano T, et al. (2013). Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in men. British Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/23308394/
  2. Sugita J, Yoneshiro T, Sugishima Y, et al. (2014). Daily ingestion of grains of paradise (Aframomum melegueta) extract increases whole-body energy expenditure and decreases visceral fat in humans. Journal of Nutritional Science and Vitaminology. https://pubmed.ncbi.nlm.nih.gov/24759256/
  3. Chung WY, Jung YJ, Surh YJ, Lee SS, Park KK (2001). Antioxidative and antitumor promoting effects of [6]-paradol and its homologs on murine skin. Mutation Research. https://pubmed.ncbi.nlm.nih.gov/11551496/
  4. Keum YS, Kim J, Lee KH, et al. (2002). Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cells. Cancer Letters. https://pubmed.ncbi.nlm.nih.gov/11809529/
  5. Bode AM, Ma WY, Surh YJ, Dong Z (2001). Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Research. https://pubmed.ncbi.nlm.nih.gov/11221868/
  6. Gaire BP, Kwon OW, Park SH, et al. (2015). Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microglia. PLoS One. https://pubmed.ncbi.nlm.nih.gov/25789481/
  7. Almatroudi A, Alsahli MA, Alrumaihi F, Allemailem KS, Rahmani AH (2019). Ginger: a novel strategy to battle cancer through modulating cell signalling pathways: a review. Current Pharmaceutical Biotechnology. https://pubmed.ncbi.nlm.nih.gov/30659535/
  8. Abdel-Naim AB, Alghamdi AA, Algandaby MM, et al. (2017). Phenolics isolated from Aframomum meleguta enhance proliferation and ossification markers in bone cells. Molecules. https://pubmed.ncbi.nlm.nih.gov/28869564/
  9. Mohammed A, Gbonjubola VA, Koorbanally NA, Islam MS (2017). Inhibition of key enzymes linked to type 2 diabetes by compounds isolated from Aframomum melegueta fruit. Pharmaceutical Biology. https://pubmed.ncbi.nlm.nih.gov/28176546/
  10. Kundu JK, Na HK, Surh YJ (2009). Ginger-derived phenolic substances with cancer preventive and therapeutic potential. Forum of Nutrition. https://pubmed.ncbi.nlm.nih.gov/19367122/
  11. Shukla Y, Singh M (2007). Cancer preventive properties of ginger: a brief review. Food and Chemical Toxicology. https://pubmed.ncbi.nlm.nih.gov/17175086/